Clinical Trial Details
EORTC-08061
Back to Clinical Trials Database
Phase II study of sunitinib (SU11248) in patients with small cell lung cancer who are either chemo-naïve (extensive disease) or have a "sensitive" relapse.
Trial Status | All trial activities ended |
---|---|
Dates |
Date of activation: 19-Feb-2009 Date Step1 close: 09-Jul-2010 |
Data management at EORTC | Yes |
Design |
Phase 2 Randomized open label |
Targeted Sample size | EORTC Groups: 48 - All Groups: 48 |
Treatment | |
Study Staff | |
Type of cancer | |
Participating groups | |
Protocol summary | http://clinicaltrials.gov/study/NCT00953459 |
NCT number | NCT00953459 |
EudraCT | 2006-002485-19 |